CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 191 enrolled
Drug / intervention
Out of cathlab insertionother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02412488
NCT02412488N/ACompleted
CompareCT.gov

Reveal LINQ™ In-Office 2 (RIO2) International Study

Medtronic Cardiac Rhythm and Heart Failure·interventional·Posted Apr 9, 2015·Updated Feb 11, 2019

In Brief

A clinical study evaluating Out of cathlab insertion for Arrhythmia. Completed, enrolled 191 participants.

Detailed Summary

The purpose of the RIO 2 International study is to provide clinical and economic evidence to support moving the LINQ™ insertion procedure outside these traditional locations within the hospital, referred to as "out-of-cathlab".

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsArrhythmia
Countries--
Collaborators--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedApr 9, 2015
Enrollment StartFeb 1, 2015
Primary CompletionSep 22, 2016
Study CompletionOct 20, 2016
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 11.2 years ago

Interventions

Out of cathlab insertionother

Insertion of the Reveal LINQ device in the "out-of-cathlab" setting (out of the operating room, cardiac catheterization or electrophysiology laboratory).